Coronary stent thrombosis: Difference between revisions
mNo edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Stent thrombosis}} | |||
{{CMG}} | {{CMG}} ; '''Associate Editors-In-Chief:''' [[ William J Gibson]], Harvard Medical School; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S. | ||
'''Associate Editors-In-Chief:''' [[William J | |||
==[[Stent thrombosis introduction|Introduction]]== | ==[[Stent thrombosis introduction|Introduction]]== | ||
Line 32: | Line 28: | ||
[[Stent thrombosis prevention#Overview|Overview]] | [[Stent thrombosis prevention#Clinical trial data|Clinical trial data]] | [[Stent thrombosis prevention#Guidelines for Prevention|Guidelines]] | [[Stent thrombosis prevention#Overview|Overview]] | [[Stent thrombosis prevention#Clinical trial data|Clinical trial data]] | [[Stent thrombosis prevention#Guidelines for Prevention|Guidelines]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Revision as of 04:02, 8 July 2011
Coronary stent thrombosis Microchapters |
Epidemiology and Demographics |
---|
Coronary stent thrombosis On the Web |
Risk calculators and risk factors for Coronary stent thrombosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editors-In-Chief: William J Gibson, Harvard Medical School; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Introduction
Definition
Overview | Issues with interpreting data | Definition based on timing of ST | Definition based on certainty of ST
Incidence
Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Sirolimus eluting stent vs Paclitaxel eluting stent | Relation to antiplatelet medications
Mechanism and Pathophysiology
Overview | Mechanisms and pathophysiology | Clinical trial data
Etiology
Predictors of stent thrombosis | Risk factors for early ST | Risk factors for late ST | Risk factors for very late ST
Premature discontinuation of antiplatelet therapy
Incidence | Predictors | Risk associated with premature discontinuation | Risk associated with late discontinuation | Duration of therapy | Failure of therapy | Prevention of premature discontinuation
Treatment
Prognosis
Recurrence of stent thrombosis | Myocardial infarction